Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Tuesday, July 29, 2025

Lucintel Forecasts the Global Wrist Pain Therapy Market to Grow with a CAGR of 6.5% from 2025 to 2031

According to a market report by Lucintel, the future of the global wrist pain therapy market looks promising with opportunities in the hospital and clinic markets. The global wrist pain therapy market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the rising incidence of wrist injuries & disorders and the growing preference for non-surgical & minimally invasive treatment options.

A more than 150-page report to understand trends, opportunity and forecast in global wrist pain therapy market to 2031 by type (medical treatement and physiotherapy), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, physiotherapy is expected to witness higher growth over the forecast period due to preference for non-invasive and conservative approaches.

Within the application category, clinic is expected to witness the higher growth due to high incidence of wrist pain and injuries.

Download sample by clicking on wrist pain therapy market.

In terms of region, North America is expected to witness the highest growth over the forecast period.

Voltarol, Baxter International, Teva Pharmaceutical Industries, Eli Lilly, Pfizer are the major suppliers in the wrist pain therapy market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Gene Therapy CRO Service Market

Galvanic Therapy Bathtub Market

Gait Therapy System Market

Fluoride Ceramic Target Market

Fixed-Line Broadband Access Equipment Market

No comments:

Post a Comment